SciClone Discloses Tentative $12.8 Million SEC Settlement over FCPA allegations
Under the terms of the proposed agreement, which has yet to be approved by the agency’s commissioners, the California-based drug manufacturer would pay a $2.5 million civil penalty, without having to admit or deny any wrongdoing.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10